伊塔科纳酸抑制室内灰尘引起的过敏气道疾病和Th2细胞分化
Yiran Li1, Shilpi Singh1, Haley A Breckenridge1
1Department of Pediatrics, Ann Arbor, MI, USA.
Mucosal immunology
|August 15, 2024
概括
由髓状细胞产生的伊塔科纳酸调节免疫反应. 研究表明,伊塔科纳酸通过抑制T助手2细胞反应来限制过敏呼吸道炎症,这表明它在喘中起着保护作用.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 过敏性疾病 过敏性疾病
背景情况:
- 伊塔科纳酸是一种由骨髓状细胞产生的抗菌代谢物.
- 伊塔科纳酸作为一种代谢和免疫调节剂.
- 过敏呼吸道疾病通常是由T助手2 (Th2) 免疫反应驱动的.
研究的目的:
- 为了研究aconitate脱碳酶1 (Acod1) 和itaconate在家尘 (HDM) 诱导的过敏气道疾病的小鼠模型中的作用.
- 为了确定Acod1缺乏是否会加剧Th2驱动的过敏炎症.
- 探索itaconate在过敏性喘中的治疗潜力.
主要方法:
- 使用了Acod1淘汰赛 (Acod1-KO) 鼠标和野生型C57BL/6鼠标,这些鼠标被挑战了HDM.
- 采用了仿真小鼠和巨细胞 (LysM-cre+Acod1flox/flox) 中的特定基因删除来评估细胞特异性作用.
- 分析了Th2细胞因子的表达,IgE水平,异氨酸性气道炎症和气道过敏反应.
- 研究了伊塔科纳酸对Th2极化CD4T细胞在体外分化的作用.
- 检查了人类喘数据集的Acod1表达水平.
主要成果:
- 在野生型小鼠中,HDM挑战增加了肺Acod1 mRNA和支气管支气管洗 (BAL) itaconate.
- 艾科德1-KO小鼠的Th2细胞因子表达增加,血清IgE增加,Th2细胞招募增强,异氨酸性气道炎症和高反应性.
- 骨髓或巨细胞中的Acod1缺乏足以引发夸张的Th2反应.
- 在体外,伊塔科纳酸治疗抑制了Th2细胞分化,并减少了关键Th2细胞因子 (IL-5,IL-13) 的产生.
- 在患有过敏性喘的人群中观察到Lower Acod1的表达.
结论:
- 通过Acod1,伊塔科纳酸在过敏原挑战后限制呼吸道2型炎症方面发挥着保护作用.
- 伊塔科纳酸减弱T细胞反应,从而减轻过敏呼吸道疾病.
- 艾科德1缺乏会加剧过敏性喘表型,这表明基于伊塔康酸的干预措施具有治疗潜力.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
255
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
255
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230
Allergic Reactions
27.3K
Overview
27.3K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964


